Jane Street’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-238,123
Closed -$4.54M 12364
2025
Q4
$5.18M Buy
238,123
+221,996
+1,377% +$6.36M ﹤0.01% 3173
2025
Q3
$526K Sell
16,127
-10,533
-40% -$389K ﹤0.01% 7756
2025
Q2
$946K Sell
26,660
-14,118
-35% -$457K ﹤0.01% 5720
2025
Q1
$1.38M Sell
40,778
-47,201
-54% -$1.69M ﹤0.01% 4971
2024
Q4
$2.86M Buy
87,979
+78,318
+811% +$3.24M ﹤0.01% 3530
2024
Q3
$471K Sell
9,661
-72,880
-88% -$3.88M ﹤0.01% 7294
2024
Q2
$3.66M Buy
82,541
+43,143
+110% +$1.99M ﹤0.01% 3466
2024
Q1
$2.21M Buy
39,398
+7,885
+25% +$476K ﹤0.01% 3948
2023
Q4
$1.9M Sell
31,513
-1,092
-3% -$69.2K ﹤0.01% 4412
2023
Q3
$2.19M Sell
32,605
-6,033
-16% -$419K ﹤0.01% 3898
2023
Q2
$2.67M Buy
38,638
+31,863
+470% +$2.08M ﹤0.01% 3698
2023
Q1
$327K Buy
+6,775
New +$331K ﹤0.01% 7052
2022
Q4
Sell
-26,972
Closed -$1.31M 9681
2022
Q3
$1.1M Buy
26,972
+10,659
+65% +$500K ﹤0.01% 5248
2022
Q2
$897K Sell
16,313
-6,785
-29% -$287K ﹤0.01% 5695
2022
Q1
$839K Sell
23,098
-4,024
-15% -$159K ﹤0.01% 6485
2021
Q4
$1.26M Buy
27,122
+15,964
+143% +$810K ﹤0.01% 5423
2021
Q3
$564K Sell
11,158
-17,028
-60% -$709K ﹤0.01% 7058
2021
Q2
$1.16M Sell
28,186
-101,116
-78% -$3.44M ﹤0.01% 5523
2021
Q1
$3.75M Buy
+129,302
New +$3.53M ﹤0.01% 2855
2020
Q3
Sell
-44,171
Closed -$1.88M 7578
2020
Q2
$1.88M Buy
+44,171
New +$1.73M ﹤0.01% 3153

Other funds holding LEGN

Jane Street's LEGN Position: Q1 2026 in Review

Jane Street sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 238,123 shares — an estimated $4.54M sold.

Jane Street first reported a position in LEGN in Q2 2020 and held it in 20 quarters. The position peaked at $5.18M in Q4 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Jane Street reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 238,123 Legend Biotech shares in Q1 2026, an estimated $4.54M.
  • Jane Street first reported a position in Legend Biotech in Q2 2020 and held it in 20 quarters.
  • Jane Street's Legend Biotech position peaked at $5.18M in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.